Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives

Pharmaceutical Research

Volumn 14, Issue 2, 1997, Pages 213-217

  Levi, Micha ^a   Yagen, Boris ^a   Bialer, Meir ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Antiepileptic activity; Pharmacokinetics; Structural requirements; Valproic acid; Valproyl hydroxamine acid derivatives

Indexed keywords

HYDROXAMIC ACID DERIVATIVE; VALPROIC ACID; VALPROIC ACID DERIVATIVE; VALPROMIDE;

ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; DRUG SYNTHESIS; DRUG URINE LEVEL; FEMALE; GAS CHROMATOGRAPHY; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTICONVULSANTS; BIOTRANSFORMATION; DOGS; HYDROXAMIC ACIDS; MICE; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; VALPROIC ACID;

EID: 0031004264     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012009012850     Document Type: Article

References (16)

1. R. H. Levy and D. D. Shen. In R. H. Levy, R. H. Mattson and B. S. Meldrum (eds) Antiepileptic Drugs, 4th Ed. Raven Press, 1995, pp. 605-620 and chapters cited therein.
2. R. H. Levy and J. K. Penry. Idiosyncratic reactions to valproate: clinical risk patterns and mechanism of toxicity. Raven Press, 1991.
3. M. Bialer, A. Haj-Yehia, K. Badir, and S. Hadad. Pharm. World Sci. 16:2-6 (1994).
4. M. Bialer. Clin. Pharmacokinet. 20:114-122 (1991).
5. H. Nau and A. G. Hendrickx. ISI Atlas Sci. Pharmacol. 52-56 (1987).
6. C. M. Regan, O. M. Larsson, M. L. Martin, A. Schousboe, and D. C. Williams. Toxic In Vitro 1:77-82 (1991).
7. A. Haj-Yehia and M. Bialer. J. Pharm. Sci. 79:719-724 (1990).
8. A. Haj-Yehia, S. Hadad, and M. Bialer. Pharm. Res. 9:1058-1063 (1992).
9. M. Bialer, S. Hadad, B. Kadry, A. Abdul-Hai, A. Haj-Yehia, J. Sterling, Y. Herzig, and B. Yagen. Pharm. Res. 13:284-289 (1996).
10. R. J. Porter, J. J. Ceregino, G. D. Gladding, B. J. Hessie, H. J. Kupferberg, B. Scoville, and B. G. White. Cliv. Clin. Q. 51:293-305 (1984).
11. M. Bialer, M. Friedman, and J. Dubrovsky. J. Pharm. Sci. 73:991-993 (1984).
12. M. Gibaldi and D. Perrier. Pharmacokinetics, 2nd Edn., Marcel Dekker, New York pp. (1982).
13. K. Yamaoka. Methods for Pharmacokinetic Analysis for Personal Computers, 2nd edn., Nanko-D Ltd., Tokyo, 145 (1986).
14. G. Johnson, P. A. Boxer, J. T. Drummond, D. K. Boyd, and R. J. Anderson. Arzneim-Forsch/Drug Res. 39:432-437 (1989).
15. K. Badir, A. Haj-Yehia, T. B. Vree, E. van der Kleijn, and M. Bialer. Pharm. Res. 8:750-753 (1991).
16. M. Bialer and A. Rubinstein. J. Pharm. Pharmacol. 35:607-609 (1983).